Named as a key player in 297 of our reports, across 33 regions and countries.
2023–2033 CAGR · estimates
| Market | Category | World 2023 | CAGR |
|---|---|---|---|
| Healthcare In Vitro Diagnostic | Healthcare Services | $83.5 Bn | 3.8% |
| Point Of Care (PoC) Molecular Diagnostic | Healthcare Services | $18.7 Bn | 9.3% |
| Bioinformatics | Healthcare Services | $12.2 Bn | 14.4% |
| Nursing Education | Healthcare Services | $10.3 Bn | 8.1% |
| Breast Cancer Diagnostic | Healthcare Services | $4.1 Bn | 7.8% |
| Brain Cancer Diagnostic | Healthcare Services | $1.5 Bn | 13.6% |
| Brain Imaging, Biomarkers and NeuroInformatics | Digital Health | $680 Mn | 4.7% |
| Antimicrobial Susceptibility Testing | Healthcare Services | – | – |
| Biological Safety Testing | Pharmaceuticals | – | – |
Named as key players in the same markets as Thermo Fisher Scientific Inc. (number of shared markets).
Siemens Healthineers6 shared markets
Abbott Laboratories5 shared markets
Danaher Corporation4 shared markets
Roche Diagnostics4 shared markets
Agilent Technologies3 shared markets
Illumina, Inc.3 shared markets
Qiagen N.V.3 shared markets
Search all reports for Thermo Fisher Scientific Inc. All companies